This report summarises respiratory pathogen PCR panel results for specimens submitted for testing to the private pathology practices that are members of the NPG from January to March 2026.NPG Respiratory Pathogen Statistics Q1
Serum biomarkers of infection such as CRP, ESR, synovial fluid leucocyte count and neutrophil percentage are useful tests to support the diagnosis of PJI. However, it is important to define the infecting microorganism to direct antimicrobial therapy. Pre-operative...
This update is a report of the PathCare susceptibility data for key surveillance organisms isolated from blood culture samples, taken from patients in the Western Cape, over a four-year period, 1 January 2022 to 31 December 2025. Bloodstream infections (BSI’s) are...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2026 (epidemiological weeks 14-18). The data is dependent on submission of samples by clinicians and therefore may not be...
PathCare antimicrobial susceptibility data for common community-acquired organisms isolated from patients in the Western Cape province during 2025 have been updated. In comparison with the previous surveillance period¹, current recommendations for empiric...
Ophthalmology specimens pose unique challenges for diagnostic microbiology. Small sample volume and urgency of clinical decision-making requires prioritized testing, thoughtful specimen handling and close communication between clinicians and the laboratory. Key...
Hypertensive disorders of pregnancy, particularly pre-eclampsia (PE), complicate around 8% of pregnancies worldwide, and account for about 500 000 perinatal deaths annually. In the South African context, hypertensive disorders are the third leading cause of maternal...
We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Anticonvulsant drug level testing is available for the following: Perampanel (Fycompa) Oxcarbazepine (Trileptal) (including...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during February 2026 (epidemiological weeks 6-9). The data is dependent on submission of samples by clinicians and therefore may not be...